Repositrak, INC Form 4 insider transactions

ReposiTrak, Inc. CEO Randall K. Fields reported the sale of 7,500 common shares through a pre-arranged 10b5-1 trading plan for charitable commitments.

ReposiTrak, Inc. CEO Randall K. Fields sold 7,500 shares of common stock in March 2026 under a pre-arranged Rule 10b5-1 trading plan for charitable commitments.

ReposiTrak's CEO, Randall K. Fields, sold 4,000 shares of common stock for charitable commitments.

ReposiTrak's CEO, Randall K. Fields, sold 7,500 shares of common stock through a pre-arranged 10b5-1 plan to fulfill charitable commitments.

ReposiTrak, Inc. CEO Randall K. Fields sold 7,500 shares of common stock through a pre-arranged 10b5-1 trading plan for charitable commitments.

ReposiTrak CEO Randall K. Fields sold 7,500 shares of common stock through a pre-arranged 10b5-1 trading plan to fulfill charitable commitments.

ReposiTrak, Inc.'s CEO, Randall K. Fields, reported the sale of 7,500 common shares through a pre-arranged 10b5-1 trading plan to fulfill charitable commitments.

ReposiTrak, Inc. CEO Randall K. Fields sold 7,500 shares of common stock at a weighted average price of $11.0742 through a pre-arranged 10b5-1 trading plan.

ReposiTrak CEO Randall K. Fields sold 7,500 shares of common stock for charitable commitments through a pre-arranged 10b5-1 trading plan.

ReposiTrak's CEO, Randall K. Fields, reported scheduled sales of 7,500 shares of common stock for January 2026, executed through a pre-arranged 10b5-1 trading plan to fulfill charitable commitments.

ReposiTrak Director Robert W. Allen reported a planned disposition of 8,280 Series B Preferred Stock shares at $10.70 per share, effective December 31, 2025, under a Rule 10b5-1 plan.

ReposiTrak, Inc. CEO Randall K. Fields reported sales of common and Series B preferred stock, including common shares sold under a 10b5-1 plan for charitable commitments.

ReposiTrak, Inc. CEO Randall K. Fields sold 7,500 shares of common stock at a weighted average price of $12.3449 to fulfill charitable commitments via a Rule 10b5-1 plan.

ReposiTrak Director Ronald C. Hodge reported the sale of 20,547 shares of common stock in late December 2025, following an earlier acquisition of shares for board service.

ReposiTrak Director Robert W. Allen acquired 1,265 shares of common stock as compensation for board service, increasing his direct beneficial ownership.

ReposiTrak CEO Randall K. Fields sold 7,500 shares of common stock in late 2025 through a pre-arranged 10b5-1 trading plan for charitable commitments.

ReposiTrak, Inc. CEO Randall K. Fields sold 7,500 shares of common stock for charitable commitments via a Rule 10b5-1 plan.

ReposiTrak's CEO, Randall K. Fields, sold 11,953 shares of common stock through a pre-arranged 10b5-1 trading plan to fulfill charitable commitments.

ReposiTrak CEO Randall K. Fields sold 3,047 shares of common stock through a pre-arranged 10b5-1 plan to fulfill charitable commitments.

ReposiTrak CEO Randall K. Fields disclosed sales of common stock totaling 7,500 shares and gifts of 200,000 shares, primarily through a charitable trust under a 10b5-1 plan.

ReposiTrak CEO Randall K. Fields sold 7,500 shares of common stock across three transactions in November 2025 under a pre-arranged 10b5-1 trading plan for charitable commitments.

ReposiTrak CEO Randall K. Fields reported the sale of 7,500 common shares from a charitable trust under a pre-arranged 10b5-1 trading plan.

ReposiTrak, Inc. CEO Randall K. Fields reported the sale of 7,500 common shares at a weighted average price of $15.0126 through a pre-arranged 10b5-1 trading plan.

ReposiTrak CEO Randall K. Fields sold 7,500 shares of common stock over three days in late October 2025, pursuant to a pre-arranged Rule 10b5-1 trading plan.

ReposiTrak CEO Randall K. Fields sold 7,500 shares of common stock for charitable commitments through a Rule 10b5-1 plan.

ReposiTrak, Inc. CEO Randall K. Fields sold 7,500 shares of common stock through a pre-arranged Rule 10b5-1 trading plan to fulfill charitable commitments.

ReposiTrak CEO Randall K. Fields sold 7,500 shares of common stock for $14.9711 per share through a pre-arranged 10b5-1 trading plan to fulfill charitable commitments.

ReposiTrak CEO Randall K. Fields sold common stock totaling 7,500 shares through a Rule 10b5-1 plan to fulfill charitable commitments.

ReposiTrak CEO Randall K. Fields sold 7,000 shares of common stock through a charitable entity under a Rule 10b5-1 trading plan.

ReposiTrak CEO Randall K. Fields sold 7,500 shares of common stock across three transactions in mid-September 2025, executed under a pre-arranged 10b5-1 trading plan for charitable commitments.